Key result
Perioperative management of antithrombotic or antiplatelet medications in gynecologic procedures requires individualized strategies for interruption, restarting, and bridging therapy.
This review outlines strategies for managing antithrombotic and antiplatelet medications perioperatively in patients undergoing gynecologic procedures.
May guide individualized antithrombotic decisions in gynecologic procedures; leaves open prospective cardiovascular trials.
The perioperative management of patients taking antithrombotic or antiplatelet medications is based on an assessment of the individual patient's risk for thrombosis or bleeding, the specific medication involved, and the nature of the planned procedure. This article describes specific strategies for whether and how these medications should be interrupted before gynecologic procedures, when they can be restarted following the procedure, and whether bridging therapy should be considered.
No takes yet. Share an insight, caveat, or question.
Fager et al. (2018) conducted a review in Gynecologic patients on long-term anticoagulation requiring perioperative management. Perioperative management strategies (interruption, restarting, bridging) was evaluated. Perioperative management of antithrombotic or antiplatelet medications in gynecologic procedures requires individualized strategies for interruption, restarting, and bridging therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: